FDA Clears Renovis’ ALIF Implant

More products based on this technology to come, company officials say.

Redland, Calif.-based Renovis Surgical Technologies Inc. has earned 510(k) clearance from the U.S. Food and Drug Administration for its Tesera stand-alone ALIF (anterior lumbar interbody fusion) cage. This 3-D printed implant is designed to create porous surfaces that aid with bone in-growth from the vertebral endplates. The Tesera ALIF implant is the first in a family of advanced spinal and orthopedic implants from Renovis to feature this platform technology.

The Tesera ALIF cage begins as a titanium alloy powder, which is melted by electron beam into a solid structure, layer by layer, transitioning into a porous structure at the surfaces. The implant is one piece, rather than multiple pieces bonded together.

Renovis introduced the device early October, and plans to release more products featuring this technology in the near future.

Renovis makes implants for orthopedics, spine and trauma.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters